As an alternative to insulin injections, MIT researchers are developing an implantable device that encapsulates islet cells, protecting them from immune rejection. The device also carries an oxygen generator to keep the cells healthy.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.